Paul Martorano

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma”.

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Communications Biology(2022)10.1038/s42003-022-04209-8

N/A

0.489DataRank · unranked

25 citations

Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel +18 more

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0400

N/A

0DataRank · unranked

31 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more

Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

(2023)10.1158/1078-0432.c.6532614.v1

N/A

0DataRank · unranked

0 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more

PARP1-targeted alpha therapy enhances target expression

EJNMMI Research(2025)10.1186/s13550-025-01256-0

N/A

0DataRank · unranked

2 citations

Paul Martorano, Hsiaoju Lee, Shuyao Geng, Vandana Batra, John M. Maris +4 more